LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $223,654 | -36.6% | 3,102 | -35.3% | 0.01% | -46.7% |
| Q1 2023 | $352,794 | -63.2% | 4,796 | -66.6% | 0.02% | -74.1% |
| Q4 2022 | $958,647 | +339.7% | 14,351 | +465.7% | 0.06% | +314.3% |
| Q3 2022 | $218,000 | -89.4% | 2,537 | -87.7% | 0.01% | -84.3% |
| Q4 2020 | $2,047,000 | -7.6% | 20,584 | -11.4% | 0.09% | -14.4% |
| Q3 2020 | $2,216,000 | +420.2% | 23,245 | +510.3% | 0.10% | +372.7% |
| Q2 2020 | $426,000 | +2.2% | 3,809 | -33.5% | 0.02% | -26.7% |
| Q1 2020 | $417,000 | -16.8% | 5,729 | +19.3% | 0.03% | +36.4% |
| Q4 2019 | $501,000 | -33.6% | 4,804 | -19.9% | 0.02% | -52.2% |
| Q1 2019 | $754,000 | -79.0% | 6,000 | -77.3% | 0.05% | -84.0% |
| Q4 2018 | $3,585,000 | -50.3% | 26,416 | +0.6% | 0.29% | -48.2% |
| Q3 2018 | $7,208,000 | – | 26,259 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |